|
|
Volumn 73, Issue 5, 1995, Pages 739-742
|
|
Resistance to activated protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACTIVATED PROTEIN C;
BLOOD CLOTTING FACTOR 5;
BLOOD CLOTTING FACTOR 5A;
ORAL CONTRACEPTIVE AGENT;
PROTEIN S;
PROTEIN C;
AMINO ACID SUBSTITUTION;
BLOOD CLOTTING TIME;
BLOOD SAMPLING;
CENTRIFUGATION;
DNA SEQUENCE;
GENE MUTATION;
GENOTYPE;
HEREDITY;
HETEROZYGOSITY;
HOMOZYGOSITY;
HUMAN;
PARTIAL THROMBOPLASTIN TIME;
PATHOGENESIS;
PHENOTYPE;
PRIORITY JOURNAL;
RISK FACTOR;
SHORT SURVEY;
THROMBOGENESIS;
VEIN THROMBOSIS;
BLOOD CLOTTING FACTOR 5 DEFICIENCY;
ENZYME ACTIVATION;
GENETIC PREDISPOSITION;
GENETICS;
LUNG EMBOLISM;
METABOLISM;
MOLECULAR GENETICS;
NUCLEOTIDE SEQUENCE;
POINT MUTATION;
POLYMERASE CHAIN REACTION;
PREVALENCE;
REVIEW;
SENSITIVITY AND SPECIFICITY;
THROMBOPHLEBITIS;
BASE SEQUENCE;
ENZYME ACTIVATION;
FACTOR V;
FACTOR V DEFICIENCY;
GENETIC PREDISPOSITION TO DISEASE;
HUMAN;
MOLECULAR SEQUENCE DATA;
PARTIAL THROMBOPLASTIN TIME;
POINT MUTATION;
POLYMERASE CHAIN REACTION;
PREVALENCE;
PROTEIN C;
PULMONARY EMBOLISM;
RISK FACTORS;
SENSITIVITY AND SPECIFICITY;
THROMBOPHLEBITIS;
|
|
EID: 0029061441
PISSN: 03406245
EISSN: None
Source Type: Journal
DOI: 10.1055/s-0038-1653860 Document Type: Short Survey |
|
Times cited : (144)
|
|
References (0)
|
